What our customers say

"I can say they delivered on every level"

Abigail Martin, PhD University of Hertfordshire, Hertfordshire, United Kingdom "Sciomics offered a professional and efficient …

"Sciomics offers excellent service and advice. I'm very satisfied."

Dr. Clarissa von Haefen Charité University Clinics, Berlin, Germany "Ich fühle mich sehr gut beraten…

"We absolutely recommend Sciomics to everyone interested in an antibody array service"

Prof. Dr. Markus GrälerUniversity Hospital Jena, SG Sepsis Research, Department of Anaesthesiology and Intensive Care…

"Sciomics Antibody Microarray really helped us to move forward"

José Pedro Castro, PhD German Instiute of Human Nutrition (DIfE), Potsdam-Rehbrücke, Germany "I am more…

"The most professional service you can expect"

Yaroslav Shcherba University Lausanne, Institut de Biotechnologie, Lausanne, Switzerland "The custom microarray slides produced by…

"Sciomics service was more than satisfactory"

Reece Marillier, PhD Ludwig Institute for Cancer Research, Brussels, Belgium "... In addition Sciomics gave…

"Comprehensive and precise results of great interest for our prospective work"

Dr. Renate Keßler Institute of Biochemistry, Medical Faculty, University of Leipzig, Germany "For our work…

"A partner who pays attention to the smallest details"

Gaith Bakdash, PhD Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, RadboudUMC, Nijmegen,…

"This has undoubtedly opened new avenues in our research"

Leonardo Guasti, PhD Barts and The London, Queen Mary's School of Medicine and Dentistry, London,…

"Impressive protein profiling service and great communication"

Dr. Andreas Vogt Assay Development, Bioassay - Labor für biologische Analytik GmbH, Heidelberg, Germany "For…

"Wir haben unser Ziel zu vollkommener Zufriedenheit erreichen können"

Prof. Dr. Matthias Gorenflo Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin, Pädiatrische Kardiologie & Angeborene…

Enabling Precision Medicine

Precison Medicine - Select the right therapy for each patient



We support and speed up Protein Biomarker Research and Discovery Programmes for Precision Medicine and Companion Diagnostic applications. Based on our unique antibody microarray platform we reduce costs and attrition rates for biomarker identification and verification projects and provide comprehensive protein expression level analysis.





Based on our proprietary system for highly-parallel protein analyses, we established a broad internal biomarker development pipeline for oncological indications as well as kidney injury. These newly developed biomarker signatures enable a precise diagnosis and patient stratification leading to a precise therapy adapted to the individual patient needs.




Products & Services

scioDiscover - Protein Expression Level Profiling

scioDiscover - Protein Expression Level Profiling

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised range of protein profiling services available. These help you to speed up your research and generate important data at lower…
Read more
scioPhospho: protein + phosphorylation profiling

scioPhospho: protein + phosphorylation profiling

scioPhospho combines the advantages of a robust and cost-efficient protein expression profiling using scioDiscover with information on phosphorylation status. This combination provides a comprehensive overview on signalling events and pathway activity regulation. 20% off for all orders before September 15th Features 900 highly relevant proteins are profiled in a single…
Read more
scioDiscover - Protein Biomarker Discovery

scioDiscover - Protein Biomarker Discovery

Personalised Medicine and Diagnostic Research require techniques to discover and verify novel and more accurate Biomarkers. We offer a comprehensive immuno-based Protein Biomarker Discovery Service using complex Antibody Microarrays. This…
scioExtract - Protein Extraction Buffers

scioExtract - Protein Extraction Buffers

The Scio-Extract Protein Extraction Buffers are optimised for superior protein isolation performance from all cell compartments and of membrane proteins. Their non-denaturing properties enable the extraction of active proteins under…
scioCD - CD-marker antibody array

scioCD - CD-marker antibody array

Characterise a certain cell type ? Cell composition in a certain tissue sample ? In-depth profiling of CD-marker expression ? Increase your throughput at high sensitivity levels ? You aim…
scioDiscover - Protein Expression Analysis

scioDiscover - Protein Expression Analysis

Our scioDiscover service enables high-content, immuno-based analysis of various biological samples leading to a comprehensive overview of proteomic changes. Key pathways in various diseases such as cancer, neurological disorders and…
scioSpot - Microarray Production

scioSpot - Microarray Production

Microarrays - tailor-made for you. With more than 10 years of experience, Sciomics is the ideal partner for designing and printing your antibody-, protein-, peptide- or DNA/RNA chips. Benefit from…
scioSpot - Custom Antibody Microarrays

scioSpot - Custom Antibody Microarrays

Antibody Microarrays - tailor-made for you. With more than 10 years of experience, Sciomics is the ideal partner for designing and printing your antibody chips as well as arrays of…
scioSpec - Antibody Specificity Assessment

scioSpec - Antibody Specificity Assessment

Be sure that your antibody is fit for your application. Profile your therapeutic or diagnostic antibody against more than 9000 human proteins. Have a comprehensive cross-reactivity and off-target reactivity profile…
scioAuto - Autoantibody Discovery

scioAuto - Autoantibody Discovery

Profile your patient samples against more than 9000 human proteins. Let us help you with our comprehensive fast and cost-effective autoantibody biomarker discovery study service. Our comprehensive autoantibody discovery service…


Interview | Advanced Biomarkers for Precision Medicine

New article | Analysis of the blood protein profile in B-cell lymphoma patients

| 12.12.2013 | There is a new article in the current issue of Proteomics Clinical Applications on an analysis of the blood protein profile of different B-cell lymphoma using complex antibody microarrays. 200 blood samples from patients with Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Chronic Lymphocytic Leukemia (CLL) as well as healthy controls were analysed and compared with each other. The study identified proteins with discriminating power among the different lymphoma types, as well as subgroups within each lymphoma entity.

Partnership | Sciomics and PEPperPRINT

| 18.11.2014 | Sciomics and PEPperPRINT are happy to announce a strategic partnership for co-distribution and co-marketing of their product and service portfolios to create a most comprehensive microarray toolbox for antibody characterization and biomarker discovery. More information.

New article | Prediction of recurrence in bladder cancer

| 08.05.2014 | In a study published in Proteomics we identified proteins with differential abundance in bladder tumours with and without a local recurrence using antibody array technology. Next to interesting differences of the two tumour subtypes from a scientific point of view, we found a protein biomarker signature with high potential for a prognosis. This could enabling urologists in future to adjust the therapy and surveillance scheme accordingly. Further validation studies are ongoing. →Case study report

License agreement | Biomarker signature | Pancreatic cancer

| 29.11.2013 | Sciomics and the German Cancer Research Center (DKFZ) signed a license agreement on a biomarker signature for a non-invasive diagnosis of pancreatic cancer. The protein biomarkers were identified in blood and urine samples using complex antibody microarrays.

2nd place | Rhein-Neckar Technology Ventures

| 22.11.2013 | Sciomics participated at the ninth round of the Rhein-Neckar Technology Venture Pitching and received second place. For the meeting at the Mafinex, a jury selected 16 start-ups out of approximately 40 competitors to present their innovative ideas to investors, companies and venture capital donors.

New article | Blood profiles of NOD-SCID and FVB mice

| 20.11.2013 | In an article in the current issue of Biospektrum,we compare protein levels in the blood of NOD-SCID and FVB mouse strains with complex antibody microarrays.